Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Rx Rundown: Merck, Gilead Sciences and Sanofi and more
This edition of Rx Rundown provides a weekly summary of medical marketing news, dealmaking, and industry chatter. Key highlights include significant acquisitions and partnerships by pharmaceutical giants like Merck, Novartis, Gilead Sciences, and Sanofi, alongside various FDA approvals and critical industry news such as Takeda’s restructuring, Pfizer’s Lyme disease vaccine trial results, and legal issues impacting social media platforms and pharmaceutical companies. Funding rounds for several biotech firms and new initiatives in healthcare technology and patient care are also covered.